On 20th January 2021, Fosun International Limited (“Fosun International” or the “Company”, 656.HK) successfully priced its US$500m 6NC4 senior fixed rate bond offering (the “Transaction”). AMTD acted as a Joint Bookrunner and Joint Lead Manager on the Transaction.
This Transaction represents the sixth transaction led by AMTD for Fosun International and other subsidiaries of Fosun Group in the international capital markets, including three USD bond offerings for Fosun International, US$450m HK IPO for Fosun Tourism Group (1992.HK) and US$438m HK IPO for Shanghai Henlius Biotech Inc. (2696.HK).
The Transaction was highly sought after by investors after started bookbuilding early in the morning with an initial price guidance of 5.45% area. The orderbook reached over US$3.5 billion at its peak, representing an oversubscription of 7x. The Transaction was eventually priced at 5.05%, which is the lowest issue yield and coupon rate ever achieved for a USD bond issue of the Company. The Transaction stands as the longest outstanding USD bond for the Company.
Fosun International is an innovation-driven consumer group, including pharmaceuticals, real estate development, steel, mining, retail, service industries and strategic investment. Fosun International has been listed on the main board of the Hong Kong Stock Exchange since 2007, with total assets of RMB715.7 billion as of 31 December 2019 and total revenue of RMB143.0 billion in 2019. Fosun International ranks 371st on the 2020 Forbes Global 2000 List and 73th in the Fortune 500 China 2020 List.